New Explosives Detector Receives DHS Approval

This post is also available in: עברית (Hebrew)

Implant Sciences Corporation announced that the QS-B220 explosives and drugs trace detector has been issued a SAFETY Act Designation from the Department of Homeland Security.

The SAFETY Act facilitates the development and deployment of effective anti-terrorism technologies by providing product liability protection. The Act creates liability limitations for claims arising out of, relating to, or resulting from an “Act of Terrorism” where Qualified Anti-Terrorism Technologies have been deployed.

iHLS – Israel Homeland Security

Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, have developed the QS-B220 to use Ion Mobility Spectrometry (IMS). This rapidly detects and identifies trace amounts of a wide variety of military, commercial, and homemade explosives.

With low maintenance requirements , the QS-B220 can be deployed for a low total cost of ownership. The device features a radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal(TM) internal automatic calibration system.